NEW YORK, Dec. 5, 2006 (PRIME NEWSWIRE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) announced today that they are in merger negotiations to acquire a clean coal technology company. The proposed agreement will include the merger candidate's patented coal technology.
The clean coal patented process is designed to increase the BTU of low quality coal which substantially increases the value of low grade lignite and sub-bituminous coal. The environmentally friendly process captures and removes harmful elements without disintegrating the coal and destroying further processing. Significantly, the patented process requires only 4-18 minutes retention time vs. the industry standard of 2-6 hours. Further development will require limited capital expenditures to be funded via grants from future partners.
APPI recently announced the signing of a Memorandum of Understanding to acquire the Biodiesel company, World Health Energy, Inc., an emerging energy company focusing on biofuels and renewable energy production and distribution. The company plans to produce and market high-quality, low cost B100 Biodiesel to replace traditional fossil fuels.
To be added to APPI's corporate e-mail list for shareholders and interested investors, please send an e-mail to ir@advancedplantpharm.com.
About Advanced Plant Pharmaceuticals, Inc. (http://www.advancedplantpharm.com)
Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of whole plant-based nutritionals. The company has a composition-oriented patent for a proprietary process of utilizing whole plants to safely manufacture all-natural nutritional supplements. APPI markets and distributes its line of products including Lo-Chol(tm) worldwide through various sales distribution channels.
"Safe Harbor Statement" Under The Private Securities Litigation Reform Act Of 1995
This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause Advanced Plant Pharmaceuticals, Inc. actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.